Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1949 3
1951 3
1953 1
1954 1
1955 4
1956 4
1957 8
1958 5
1959 9
1960 9
1961 4
1962 4
1963 5
1964 10
1965 8
1966 11
1967 12
1968 12
1969 18
1970 18
1971 22
1972 16
1973 16
1974 12
1975 19
1976 14
1977 24
1978 10
1979 14
1980 16
1981 17
1982 14
1983 14
1984 13
1985 10
1986 10
1987 11
1988 15
1989 11
1990 9
1991 10
1992 13
1993 14
1994 12
1995 21
1996 15
1997 21
1998 26
1999 18
2000 29
2001 19
2002 18
2003 20
2004 21
2005 32
2006 35
2007 27
2008 39
2009 47
2010 49
2011 68
2012 78
2013 64
2014 53
2015 60
2016 57
2017 50
2018 40
2019 45
2020 45
2021 67
2022 49
2023 50
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

1,540 results

Results by year

Filters applied: . Clear all
Page 1
Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant.
Barlev A, Zimmermann H, Guzman-Becerra N, Mehta A, Xing B, Macabeo B, Thivolet M, Brookhart MA. Barlev A, et al. Among authors: zimmermann h. J Med Econ. 2024 May 10:1-10. doi: 10.1080/13696998.2024.2354150. Online ahead of print. J Med Econ. 2024. PMID: 38727527 Free article.
Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS study.
Bayas A, Mansmann U, Ön BI, Hoffmann VS, Berthele A, Mühlau M, Kowarik MC, Krumbholz M, Senel M, Steuerwald V, Naumann M, Hartberger J, Kerschensteiner M, Oswald E, Ruschil C, Ziemann U, Tumani H, Vardakas I, Albashiti F, Kramer F, Soto-Rey I, Spengler H, Mayer G, Kestler HA, Kohlbacher O, Hagedorn M, Boeker M, Kuhn K, Buchka S, Kohlmayer F, Kirschke JS, Behrens L, Zimmermann H, Bender B, Sollmann N, Havla J, Hemmer B; ProVal-MS study group. Bayas A, et al. Among authors: zimmermann h. Neurol Res Pract. 2024 Mar 7;6(1):15. doi: 10.1186/s42466-024-00310-x. Neurol Res Pract. 2024. PMID: 38449051 Free PMC article.
Multiscale networks in multiple sclerosis.
Kennedy KE, Kerlero de Rosbo N, Uccelli A, Cellerino M, Ivaldi F, Contini P, De Palma R, Harbo HF, Berge T, Bos SD, Høgestøl EA, Brune-Ingebretsen S, de Rodez Benavent SA, Paul F, Brandt AU, Bäcker-Koduah P, Behrens J, Kuchling J, Asseyer S, Scheel M, Chien C, Zimmermann H, Motamedi S, Kauer-Bonin J, Saez-Rodriguez J, Rinas M, Alexopoulos LG, Andorra M, Llufriu S, Saiz A, Blanco Y, Martinez-Heras E, Solana E, Pulido-Valdeolivas I, Martinez-Lapiscina EH, Garcia-Ojalvo J, Villoslada P. Kennedy KE, et al. Among authors: zimmermann h. PLoS Comput Biol. 2024 Feb 8;20(2):e1010980. doi: 10.1371/journal.pcbi.1010980. eCollection 2024 Feb. PLoS Comput Biol. 2024. PMID: 38329927 Free PMC article.
1,540 results